Biohaven is a biopharmaceutical company focused on innovative treatments for neurological and neuropsychiatric disorders. It develops therapies for migraines, obsessive-compulsive disorder, and rare diseases, benefiting patients, caregivers, and healthcare providers. Its medications, including Nurtec ODT and zavegepant, offer targeted relief and improved quality of life for those with limited options.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends